Parallel Advisors’s Biomea Fusion BMEA Stock Holding History

Parallel Advisors’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-200	Closed	-$360	–	3564
2025 Q2	$360	Buy	+200	New	+$385	﹤0.01%	3347

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Parallel Advisors's BMEA Position: Q3 2025 in Review

Parallel Advisors sold out of Biomea Fusion (BMEA) in Q3 2025, closing a stake of 200 shares — an estimated $360 sold.

Parallel Advisors first reported a position in BMEA in Q2 2025 and held it in 1 quarter. The position peaked at $360 in Q2 2025. 73 funds tracked by Wall St. Rank hold BMEA as of Q3 2025.

Parallel Advisors reported no remaining Biomea Fusion position as of Q3 2025 after selling out during the quarter.
Parallel Advisors sold 200 Biomea Fusion shares in Q3 2025, an estimated $360.
Parallel Advisors first reported a position in Biomea Fusion in Q2 2025 and held it in 1 quarter.
Parallel Advisors's Biomea Fusion position peaked at $360 in Q2 2025.
73 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.